[1] 孙志涛,周正新,牛维,等.骨痹通消颗粒胶囊对激素性股骨头坏死模型兔凝血机制的影响[J].中国组织工程研究, 2012,16(7): 1295-1298.[2] 周正新,孙志涛,丁锷等.骨痹通消颗粒胶囊对激素性股骨头坏死患者凝血机制的影响[J].中医正骨,2013,25(3):31-34.[3] 李文君,周正新.骨痹通消颗粒Ⅰ号胶囊对激素性股骨头缺血性坏死TGF-β1表达的影响[J].中国民族民间医药, 2013,22(18): 13-14.[4] 李春峰,孙志涛,周正新,等.不同剂量骨痹通消颗粒胶囊对兔激素性股骨头坏死微循环的影响[J].中国组织工程研究, 2013,(20): 3723-3729.[5] 暴淑英,赵庆国,毕黎琦,等.激素性股骨头坏死早期细胞凋亡相关基因表达及阿仑磷酸钠的干预[J].中国组织工程研究与临床康复,2008,12(46):9095-9099.[6] 贾岩波,刘万林,任逸众等.激素性股骨头坏死发病机制中细胞凋亡的研究进展[J].中国组织工程研究,2012,16(13):2444-2450.[7] 吉浩宇,王小龙.早期激素性股骨头坏死过程中细胞色素c的作用[J].中国组织工程研究,2016,20(42):6252-6258.[8] 田雷,王坤正,党晓谦,等.阿魏酸钠对兔激素性股骨头坏死早期的干预作用及对骨细胞凋亡的影响[J].西安交通大学学报(医学版), 2011,32(2):220-225,266.[9] 张立岩,孙新,田丹,等.-2基因转染骨髓干细胞治疗激素性股骨头坏死的疗效研究[J].中国现代医学杂志,2017,27(14):19-23.[10] 席红波,黄立新,董天华,等.左旋多巴干预激素性股骨头坏死中骨细胞凋亡的实验研究[J].中华骨科杂志,2010,30(1):73-78.[11] Wan J, Zhang XS. Percutaneous femoral head arthroplasty using calcium phosphate cement maybe a more feasible way to cure avascular necrosis of femoral head: Comment on "Calcium phosphate cement to prevent collapse in avascular necrosis of the femoral head". Med Hypotheses.2010;75(1): 132-132.[12] 赵振群,刘万林,龚瑜林,等.骨髓造血细胞DNA氧化损伤与骨细胞凋亡在早期激素性股骨头坏死中的表现[J].中国组织工程研究,2015,(11):1652-1657.[13] 胡峰,赵劲民,李晓峰,等.早期激素性股骨头缺血性坏死模型的建立及半胱天冬酶3活性测定[J].中国组织工程研究与临床康复, 2010,14(20):3701-3704.[14] 宋奕,丁道芳,李玲慧,等.细胞凋亡在激素性股骨头坏死机制中的研究进展[J].中国矫形外科杂志,2013,21(21):2163-2165.[15] 李挺松,肖增明,黄秋嫔,等.降脂抗凝联合作用对兔激素性股骨头坏死骨细胞凋亡的影响[J].中国医科大学学报, 2014,(5): 441-445.[16] Ai ZS, Gao YS, Sun Y, et al. Logistic regression analysis of factors associated with avascular necrosis of the femoral head following femoral neck fractures in middle-aged and elderly patients. J Orthop Sci. 2013;18(2):271-276.[17] 彭昊,陈森,李建平,等.小剂量促红细胞生成素对大鼠激素性股骨头坏死的影响及其机制[J].中华实验外科杂志, 2014,31(11): 2521-2523,封3.[18] 许心弦,温宏,吕杨训,等.信号传导及转录激活因子1诱导骨细胞凋亡在激素性股骨头坏死过程中的作用[J].中医正骨, 2014, 26(2):3-7.[19] 田能,孔祥英,万蓉,等.健脾活血方对激素性股骨头坏死血管内皮生长因子表达的影响[J].中国实验方剂学杂志, 2010,16(2): 48-51.[20] 陈晓波,陈雷雷,洪郭驹,等.桃红四物汤对激素性股骨头坏死兔股骨头微结构的影响及其机制[J].山东医药,2017,57(32):5-9.[21] 于雪峰,陈凯云,吕岫华,等.基于中医“治未病”理论探讨骨蚀灵胶囊预防激素性股骨头坏死的实验研究[J].中国中医药科技, 2014, 21(4):369-371.[22] 耿艳华,王昌兴,石仕元,等.补肾活血方对早期激素性股骨头坏死血液粘滞性基因表达影响的研究[J].浙江临床医学, 2016,(1): 11-13.[23] 李洪涛,程永志,孙晓伟,等.骨蚀灵胶囊对兔早期激素性股骨头坏死骨组织VEGF mRNA表达的影响[J].中国中医药科技, 2015, 22(4):389-390,397.[24] 吉万波,刘冠虹,刘锦涛,等.股密葆方对大鼠激素性股骨头坏死脂质代谢影响的实验研究[J].中国骨质疏松杂志, 2016,22(12): 1580-1584.[25] 徐英杰,尹羽薇,肖正权,等.生骨胶囊对兔早期激素性股骨头坏死骨组织BMP-2、PPAR-γ表达影响的研究[J].中医药学报, 2015, (1):19-22.[26] Vardhan H, Tripathy SK, Sen RK, et al. Epidemiological profile of femoral head osteonecrosis in the North Indian Population. Indian J Orthop. 2018;52(2):140-146. [27] Ren X, Fan W, Shao Z, et al. A metabolomic study on early detection of steroid-induced avascular necrosis of the femoral head. Oncotarget. 2018;9(8):7984-7995. [28] Pu R, Peng H. 11β-hydroxysteroid dehydrogenases as targets in the treatment of steroid-associated femoral head necrosis using antler extract. Exp Ther Med. 2018;15(1): 977-984. [29] Xue XH, Feng ZH, Li ZX, et al. Salidroside inhibits steroid-induced avascular necrosis of the femoral head via the PI3K/Akt signaling pathway: In vitro and in vivo studies. Mol Med Rep. 2018;17(3):3751-3757. [30] Zhao FC, Hu HX, Zheng X, et al. Clinical analysis of 23 cases of steroid-associated osteonecrosis of the femoral head with normal initial magnetic resonance imaging presentation.Medicine (Baltimore). 2017;96(49):e8834. [31] Li J, Wang J, Zhao J, et al. BOLD-MRI early detect femoral head osteonecrosis following steroid-treated patients. Medicine (Baltimore). 2017;96(44):e8401. [32] Dong Y, Li T, Li Y, etal.MicroRNA-23a-3p inhibitor decreases osteonecrosis incidence in a rat model.Mol Med Rep. 2017; 16(6):9331-9336. [33] Tian ZJ, Liu BY, Zhang YT, et al. MiR-145 silencing promotes steroid-induced avascular necrosis of the femoral head repair via upregulating VEGF. Eur Rev Med Pharmacol Sci. 2017; 21(17):3763-3769.[34] Pei J, Fan L, Nan K, et al. Excessive Activation of TLR4/NF-κB Interactively Suppresses the Canonical Wnt/β-catenin Pathway and Induces SANFH in SD Rats. Sci Rep. 2017;7(1):11928. [35] Narayanan A, Khanchandani P, Borkar RM, et al. Avascular necrosis of femoral head: a metabolomic, biophysical, biochemical, electron microscopic and histopathological characterization. Sci Rep. 2017;7(1):10721. |